Frankfurt Hall Industry Satellite Symposium

Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer (ID 26)

Date
Thu, 11.05.2023
Time
11:30 - 12:30
Room
Frankfurt Hall
Chairs
  • Sherko Kuemmel (Essen, Germany)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer

Welcome and introductions (ID 12)

Lecture Time
11:30 - 11:35
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • Sherko Kuemmel (Essen, Germany)
Authors
  • Sherko Kuemmel (Essen, Germany)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer

First-line treatment in HR+/HER2- ABC: Patient cases (ID 13)

Lecture Time
11:35 - 12:00
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • Sherko Kuemmel (Essen, Germany)
Authors
  • Sherko Kuemmel (Essen, Germany)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer

Sequencing following progression after first-line CDK4/6i: Patient cases (ID 14)

Lecture Time
12:00 - 12:20
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • Michelino De Laurentiis (Napoli, Italy)
Authors
  • Michelino De Laurentiis (Napoli, Italy)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer

Closing and key takeaways (ID 15)

Lecture Time
12:20 - 12:25
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • To be Announced (Barcelona, Spain)
Authors
  • To be Announced (Barcelona, Spain)
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer

Live Q&A (ID 16)

Lecture Time
12:25 - 12:30
Session Name
Novartis - Decision-making in a dynamic treatment landscape: Discussions on challenging patient cases in HR+/HER2- advanced breast cancer
Room
Frankfurt Hall
Date
Thu, 11.05.2023
Time
11:30 - 12:30
Speakers
  • To be Announced (Barcelona, Spain)
Authors
  • To be Announced (Barcelona, Spain)